Position in ADMA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,007,167
-$759,353 QoQ
Shares Held
239,805
-21.9% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 323 holders
Holding Since
Sep 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRUDENTIAL FINANCIAL INC holds $556,047,667 across 189 Biotechnology names. ADMA ranks #54 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
130,659 | $81,471,112 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
133,294 | $66,211,127 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
392,811 | $22,476,644 | |
| 4 | INCY |
Incyte Corp
|
191,312 | $21,687,128 | |
| 5 | CYTK |
Cytokinetics Inc
|
214,535 | $18,276,236 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
54,623 | $17,265,784 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
185,820 | $15,157,337 | |
| 8 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
2,152,154 | $13,429,440 |
All Filings in ADMA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,007,167 | 239,805 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,766,520 | 307,050 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $5,934,384 | 325,350 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $6,477,227 | 441,830 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $9,081,327 | 498,700 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $9,881,014 | 498,035 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $8,993,974 | 524,430 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $10,365,474 | 518,533 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,422,517 | 395,574 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $239,817 | 36,336 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $61,426 | 13,590 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $46,683 | 13,040 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $48,117 | 13,040 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $39,918 | 12,060 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $45,590 | 11,750 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $37,543 | 15,450 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $64,647 | 32,650 | Shares | Defined | 2022-08-15 | |
| 2021-03-31 | $22,719 | 12,909 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $21,310 | 10,929 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $26,120 | 10,929 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||